title: Myofibroblast persistence in fetal sheep wounds is associated with scar formation.
abstract: The scarless repair capabilities of the fetus are influenced by the size of the wound and the gestational age of the fetus. Whereas small wounds heal scarlessly, large wounds in the same fetus heal with scar. Myofibroblasts are specialized fibroblasts that express alpha-smooth muscle actin (alpha-SMA), a contractile cytoskeletal protein. The authors hypothesized that small fetal wounds that heal scarlessly will have a relative absence of myofibroblasts, whereas large wounds that heal with scar will have abundant myofibroblasts. In this study, an incisional wound and four punch biopsy wounds of 2, 4, 6, and 10 mm diameter were placed on the backs of 60- to 90-day-gestation fetal sheep (term, 145 days). Fourteen days after wounding, the healed fetal wounds were harvested, the repair morphology was determined (scarless, transitional repair, or scar), and the expression of alpha-SMA was analyzed by immunohistochemistry. In the second part of this study the authors analyzed the temporal expression of alpha-SMA in fetal wounds at 1, 2, 3, and 7 days after wounding in 70-day-gestation fetal sheep. In the 14-day wounds, the authors found that alpha-SMA was not expressed in any incisional or 2-mm wound that healed scarlessly, but it was expressed in all wounds that healed with scar. Overall, alpha-SMA expression strongly correlated with increasing wound size (P < .005). Myofibroblasts were seen as early as 24 hours after wounding, and at 3 and 7 days all wounds showed strong expression of alpha-SMA. These results demonstrate that although myofibroblasts are induced early in fetal wound repair, by 14 days there is a notable lack of myofibroblasts in wounds that heal scarlessly and an abundance of myofibroblasts in those wounds that scar. By determining the factors that regulate the disappearance of the myofibroblast in scarless fetal wounds, the authors hope to gain new insights into the mechanisms of scarless fetal repair.
authors.affiliation: The Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, and the University of Pennsylvania School of Medicine, 19104, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Cass
authors.forename: K G
authors.initials: KG
authors.lastname: Sylvester
authors.forename: E Y
authors.initials: EY
authors.lastname: Yang
authors.forename: T M
authors.initials: TM
authors.lastname: Crombleholme
authors.forename: N S
authors.initials: NS
authors.lastname: Adzick
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D002921:Cicatrix / Q000196:embryology* / Q000473:pathology; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D005865:Gestational Age; D007150:Immunohistochemistry; D009130:Muscle, Smooth / Q000166:cytology / Q000378:metabolism; D011247:Pregnancy; D012756:Sheep; D018709:Statistics, Nonparametric; D014945:Wound Healing / Q000502:physiology*
chemical_list: D000199:Actins